Case Series
To gain a detailed understanding of the effect of add-on nabiximols on spasticity-related symptoms at an individual level, this case series evaluates symptom evolution in patients with multiple sclerosis spasticity and variable baseline spasticity-related symptoms.
Original Research
This analysis confirms that the tolerability and safety profile of edivoxetine as adjunctive treatment to SSRI antidepressants was consistent with its norepinephrine reuptake inhibitor mechanism of action, and was comparable with edivoxetine monotherapy treatment in patients with major depressive disorder.
